Share this article
ATLANTA, April 1, 2021 /PRNewswire/
GoHealth Urgent Care, one of the country s largest, fastest-growing on-demand care companies, has teamed up with American Airlines to provide pre-flight COVID-19 testing for travelers at over 150 centers nationwide. Prior to their departure date, travelers will have the option to have a PCR or Rapid Molecular COVID-19 Test at a nearby GoHealth Urgent Care center to provide peace of mind that they have fulfilled the travel requirements for their destination. Rapid PCR Testing will also be available soon at select centers.
American Airlines customers across the country will have flexible options for both pre-test evaluations and the tests themselves. The clinical evaluations and tests can be completed in a number of convenient ways:
Share this article
Share this article
ResearchAndMarkets.com s offering.
According to this report the global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. It is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.
The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.
Nine Bascom Palmer doctors named to Power List Honoring Top Women in Ophthalmology
News provided by
Share this article
Share this article
MIAMI, April 1, 2021 /PRNewswire/ Nine esteemed ophthalmologists at Bascom Palmer Eye Institute were selected for
The Ophthalmologist Power List 2021, which honors the world s 100 most influential women in the field of ophthalmology.
Audina M. Berrocal, M.D., Hilda Capo, M.D., Janet L. Davis, M.D., M.B.A., Kendall E. Donaldson, M.D., M.S., Anat Galor, M.D., Alana Grajewski, M.D., Ranya G. Habash, M.D., Carol L. Karp, M.D., and Sonia Yoo, M.D., were named to the Power List as published in
PTC Therapeutics Announces Commercial Milestone Payment Following the Recent European Approval of Evrysdi™
News provided by
Share this article
Share this article
SOUTH PLAINFIELD, N.J., April 1, 2021 /PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that a $20 million milestone payment was triggered by the first commercial sale of Evrysdi™ (risdiplam) in the European Union under its License and Collaboration Agreement with Roche. Approval for Evrysdi from the European Medicines Agency was received on March 30 for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older. We are happy to see the rapid adoption of Evrysdi in the EU which speaks to the need for new treatments for SMA patients, said Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics. We are delighted that an effective at-home therapy will be available to SMA patients. We recognize that a large proportion of SMA patients in the EU are current
Share this article
WASHINGTON, April 1, 2021 /PRNewswire/
Furthering its commitment to accelerate vaccination for frontline meat and poultry workers and assist vaccination efforts for all Americans, the North American Meat Institute (Meat Institute) today (Thursday) became a founding member of the national
COVID-19 Community Corps, a U.S. Department of Health and Human Services (HHS) initiative.
Meat and poultry workers are eligible to receive vaccines in 44 states (source:
Food and Environment Reporting Network), but increased supplies and distribution are urgently needed to build on comprehensive measures instituted since spring 2020 that have brought case rates nearly 90% lower than in the general population.